Patricia Boksa conducts research on pregnancy and birth complications as risk factors for the later development of schizophrenia.

Natalie Grizenko is medical director with the mandate of integrating research, teaching and clinical excellence throughout the program.

Gustavo Turecki investigates the neurobiology of suicide, focusing on the role of genetic risk factors.

Duncan Pedersen studies how societies impact the mental health of their citizens. His work focuses on Latin America.

Jacques Tremblay is actively involved in quality assurance, and in improving the safety of medication use.

N.P. Vasavan Nair, M.D., FRCPC, has contributed to the Douglas Institute in a variety of capacities.

Alain Gratton, PhD, investigates the role of dopamine in drug abuse, as well as exposure to stress.

Jean Caron's research relates mainly to the epidemiology of mental illnesses and suicide.

Researchers examining the “Mood, Anxiety, and Impulsivity-related Disorders” theme are aiming to identify the genetic , psychological, neurobiological and environmental causes of most mood disorders and testing the most effective treatments. Their main focus is on: Depression Bipolar disorder Personality disorders Post-traumatic stress disorder Eating disorders Substance dependence, e.g. drug or alcohol Suicide Identifying risk factors and responding ef...

The researchers exploring the “Schizophrenia and neurodevelopmental disorders” theme focus on the causes, course, treatment and prevention of: Schizophrenia and other psychotic disorders Attention deficit hyperactivity disorder (ADHD), conduct disorder, oppositional defiant disorder and Gilles de la Tourette syndrome Autism (research and evaluation) In Canada, one in a hundred people will be diagnosed with schizophrenia while 3 to 5% of children have an attention deficit...